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ABSTRACT
Objectives: The objective of the present work is to study the in vivo anti-oxidant and hepatoprotective effects of Hugonia mystax in paracetamol (PCM) 
induced hepatotoxicity in rats.
Methods: The in vivo anti-oxidant activity of 70% ethanol extract of leaves of H. mystax (HMEE) was assessed by determining the tissue glutathione 
and lipid peroxidation (LPO) levels. HMEE 200 and 400 mg/kg p.o. doses and silymarin p.o.100 mg/kg were administered to the PCM challenged 
rats. The effect of HMEE and silymarin on physical (liver weight and liver volume) and biochemical parameters (serum enzymes [serum glutamic 
oxaloacetic transaminase (SGOT) and serum glutamate-pyruvate transaminase (SGPT)], alkaline phosphate [ALP], and bilirubin) were measured. 
Furthermore, histopathological changes in the liver were studied.
Results: The HMEE showed in the vivo anti-oxidant activity. Pre-treatment with HMEE for 7 days significantly reduced the elevated biochemical 
parameters (SGOT, SGPT, ALP, and bilirubin levels). The hepatic damage in animal pretreated with HMEE was minimal with distinct preservation of 
structures and architectural frame of the hepatic cells.
Conclusion: These findings demonstrate the protective nature of HMEE against PCM induced hepatotoxicity in rats.
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INTRODUCTION
Many therapeutic agents cause liver damage, which manifest clinically 
as hepatitis or only as laboratory abnormality (e.g. increased plasma 
aspartate transaminase activity). Mild drug-induced abnormalities of 
liver function are not uncommon, but the mechanism of liver injury is 
often uncertain. Hepatotoxicity caused by toxic doses of paracetamol 
(PCM) is clinically important (about 30,000 patients are admitted to 
the UK hospitals every year with PCM poisoning) [1]. No reliable drugs 
are available in the allopathic system to cure liver disease. Herbal 
medicines derived from plant extracts are increasingly being utilized. 
Hence, the present study was planned to exploit the safety and efficacy 
of Hugonia mystax.
H. mystax, family Linaceae, is a rambling scandent scrub with yellow 
tomentose twigs and branchlets horizontal provided with a pair of 
strong hooks. Leaves are simple, alternate, elliptic-obovate glabrous, 
and penninerved [2]. Literature review mentioned that the roots are 
astringent, bitter, sweet, febrifuge, and anthelmintic. They are useful in 
fevers, verminosis, and vitiated conditions of vata, externally as a paste 
for inflammation [3]. Bark of the root is also employed as an antidote 
to poison [4]. The modern literature revealed that the plant is reported 
to possess anti-microbial activity [5-7], anti-inflammatory activity [8], 
in vitro cytotoxic effect [9], and in vitro anthelmintic activity [10].
Preliminary phytochemical analysis of HMEE revealed the 
presence of flavonoids, tannins, and saponins. There are reports 
that the polyphenolic compounds are possessing anti-oxidant and 
hepatoprotective effects [11]. Hence, the objective of the present 
investigation was to study the effect of ethanol extract of H. mystax 
leaves (HMEE) on physical, biochemical, in vivo anti-oxidants, and 
histopathological parameters against PCM induced liver damage in rats.
METHODS
Plant material and preparation of HMEE
The leaves of plant H. mystax were collected from the fields of Tirupati, 
Andhra Pradesh. It was identified and authenticated by Dr. K. Madhava 
Chetty, plant taxonomist, Department of Botany, Sri Venkateswara 
University, Tirupati, Andhra Pradesh. An herbarium specimen was 
preserved in the college herbal museum. The leaves were shade dried at 
room temperature and pulverized. The ethanol extract was prepared by 
using 70% ethanol in a soxhlet apparatus after de-fatting with petroleum 
ether and chloroform. Preliminary phytochemical investigation showed 
the presence of flavonoid, tannin, and saponins in 70% HMEE. Hence, 
HMEE was selected for the study of hepatoprotective activity.
Animals
Wistar albino rats (150-220 g) and mice (18-25 g) of either sex were 
used for the study. Approval from the Institutional Animal Ethical 
Committee (1555/PO/a/11/CPCSEA) for usage of the animal in the 
experiment was obtained as per the Indian CPCSEA guidelines.
Acute toxicity studies
The acute toxicity was determined on albino mice by fixed dose method 
of OECD Guide line no 420 given by CPCSEA [12].
Experimental designs
PCM induced hepatotoxicity [13]
Albino rats were randomly assigned into five groups of six animals 
each. Group I and Group II received normal saline (1 ml/kg) for 7 days. 
Group III received 100 mg/kg silymarin (standard drug) orally for 
7 days. Group IV and Group V received 100 mg/kg and 200 mg/kg HMEE 
(orally). On 5th day, 30 minutes after the administration of normal saline, 
100 mg/kg silymarin, 100 mg/kg, and 200 mg/kg of HMEE to Groups II, 
Research Article
Asian J Pharm Clin Res, Vol 8, Issue 5, 2015, 291-294
 Shirode et al. 
292
III, IV, and V, respectively, PCM 2 g/kg was given orally. After 48 hrs of 
PCM feeding, blood samples were collected under mild ether anesthesia 
and were sacrificed by cervical dislocation and liver tissue was collected.
Biochemical studies
Blood was obtained from all the animals by puncturing retro-
orbital plexus. The collected blood was centrifuged (2000 rpm for 
10 minutes) to get clear serum and was used to estimate the various 
biochemical markers such as serum glutamate-pyruvate transaminase 
(SGPT) [14], serum glutamic oxaloacetic transaminase (SGOT) [15], 
alkaline phosphate (ALP) [16], and bilirubin (total and direct) [17].
Histopathology
The liver was dissected out and stored in 10% formalin solution. The 
liver was processed for the histopathological investigations.
In vivo tissue glutathione (GSH) estimation
Tissue GSH measurements were performed using a modification of 
Ellman procedure [18]. Liver tissue samples were homogenized in ice 
cold trichloroacetic acid (TCA) (1 g tissue in 10 ml 10% TCA) in an ultra 
trux tissue homogenizer. The mixture was centrifuged at 3000 rpm 
for 10 minutes. Then 0.5 ml of supernatant was added to 2 ml of 
(0.3 M) disodium hydrogen phosphate solution. A 0.2 ml solution of 
dithiobisnitrobenzoate (0.4 mg/ml in 1% sodium acetate) was added 
and the absorbance was recorded at 412 nm.
In vivo lipid peroxidation (LPO) estimation
The degree of lipid peroxide formation was assayed by monitoring the 
formation of thiobarbituric reactive substance [19]. 1.0 ml of biological 
sample (0.1-2.0 mg of membrane protein or 0.1-2.0 μmol of lipid 
phosphate) was added to 2.0 ml of TCA-thiobarbituric acid and HCL 
solution mixed thoroughly. The solution was heated for 1 hr and cooled. 
Then the precipitate was removed by centrifugation at 1000 rpm 
for 10 minutes and the absorbance of the sample was determined at 
535 nm against a blank that contain all the reagents minus lipid.
Statistical analysis
Results were expressed as mean ± standard error of the mean (n=6). 
Statistical analysis was performed with one-way ANOVA followed by 




No mortality was observed up to 2000 mg/kg of dose in mice. Therefore, 
1/10th and 1/5th (200 mg/kg and 400 mg/kg) doses were selected for 
the study.
In vivo tissue GSH and LPO
In the present study, depletion of GSH level in liver was observed 
in PCM intoxicated group, while pretreatment of HMEE enhanced 
the GSH level by 61.04% and 76.02% at the doses of 200 mg/kg and 
400 mg/kg, respectively. Silymarin 100 mg/kg increased tissue GSH 
by 97.28% (Fig. 1). PCM enhanced the LPO. The treatment with HMEE 
significantly reduced the LPO in a dose dependent manner. Silymarin 
100 mg/kg showed 51.94% inhibition, whereas 200 mg/kg of HMEE 
showed 50.92% inhibition, which is comparable to silymarin (Fig. 2).
PCM induced hepatotoxicity
Administration of PCM in intoxicated control group elevated the serums 
levels of SGOT, SGPT, ALP, and bilirubin (direct and total) significant 
(p<0.05). In the present study, HMEE at doses of 200 mg/kg and 
400 mg/kg not only prevented the rise in serum level of SGOT, SGPT, 
ALP, and bilirubin (total and direct) (Table 1) but also improved the 
liver weight (Fig. 3) and liver volume (Fig. 4) in a dose dependent 
manner. The histopathological observations (Fig 5) of PCM induced 
hepatotoxicity also were normalized by the treatment of HMEE. These 
assessments indicate that the HMEE possess hepatoprotective activity 
against PCM induced hepatotoxicity.
Histopathological studies
Group I:  Normal control showing mild sinusoidal congestion or NAD 
(no abnormality detected) (H and E, ×40).
Group II:  Intoxicated control is showing severe fatty degeneration, 
ballooning of hepatocytes, infiltration of lymphocytes, and 
congested sinusoids.
Group III:  PCM±100 mg/kg silymarin showing normal liver 
architecture with minimal hepatocytes degeneration and 
normal central vein.
Group IV:  PCM±200 mg/kg HMEE is showing moderate fatty changes 
in hepatocytes and degeneration of hepatocytes.
Group V:  PCM±400 mg/kg HMEE is showing recovery of liver 
Fig. 3: Effect of ethanol extract of leaves of Hugonia mystax on 
liver weight in paracetamol induced hepatotoxicity in rats
Fig. 4: Effect of ethanol extract of leaves of Hugonia mystax on 
liver volume level in paracetamol induced hepatotoxicity in rats
Fig. 1: Effect of ethanol extract of leaves of Hugonia mystax on tissue 
glutathione level in paracetamol induced hepatotoxicity in rats
Fig. 2: Effect of ethanol extract of leaves of Hugonia mystax on 
lipid peroxidation levels in paracetamol induced hepatotoxicity 
in rats
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architecture with minimal infiltration of mononuclear cells 
and congestion of sinusoids. Central vein is normal (H and 
E, ×40).
DISCUSSION
There are reports that toxic dose of PCM induced hepatotoxicity is due 
to activation of PCM to a toxic electrophile N-acetyl p-benzoquinone 
amine (NAPQI) by a number of isoenzyme of CYP-450 namely CYP 2E1, 
CYP 1A2, CYP 2A6, CYP 3A4, and CYP 2D6. Normally, PCM is eliminated 
from the body as sulfate and glucuronide to the extents of 95% before 
oxidation. However, 5% of PCM undergoes bioactivation by above 
mentioned isoenzymes of CYP to a highly reactive NAPQI [20].
After the over dosage of PCM, routes of sulfation and glucuronidation 
saturates. As a consequence, oxidation of PCM by CYP-450 isoenzymes 
are increased leading to the increased concentration of NAPQI. This 
NAPQI further loses one electron resulting into the toxic radical. 
This radical interact covalently with membrane macromolecules and 
damage the membrane. However, this radical is countered by inbuilt 
tissue anti-oxidants systems such as GSH. Excessive concentration 
of NAPQI radicals over powers the inbuilt protecting mechanisms 
thereby causing the membrane damage and necrosis, which releases 
the biochemical marker enzymes into circulation.
In tissues, SGPT and SGOT are found in higher concentration in 
cytoplasm [21]. In liver injury, the transport function of the hepatocytes 
is disturbed resulting in the leakage of plasma membrane [22], thereby 
serum level of SGPT and SGOT are increased due to cellular leakage and 
loss of functional integrity of cell membranes in liver [23]. In the HMEE 
treated group, the reduced levels of elevated SGPT and SGOT may be 
a result of the stabilization of plasma membrane as well as repair of 
hepatic tissue damage caused by an overdose of PCM.
ALP is normally excreted via bile by the liver. In liver injury due to 
hepatotoxin, there is a defective excretion of bile by the liver which is 
reflected in their increased levels in serum [24]. HMEE significantly 
prevented the rise in serum level of bilirubin together with the 
suppression of the activity of ALP in the serum. This suggests the 
possibility of the HMEE being able to stabilize biliary dysfunction of rat 
liver during PCM induced hepatotoxicity in rats.
Overall, it is apparent from the results that treatment with HMEE 
prevents the formation of one electron reduced metabolite of NAPQI. 
Further, this may be helpful in retaining the membrane GSH contents, 
reduced LPO, and prevents the tissue damage. In this model, the present 
study does not rule out the possibility of involvement of the first step of 
CYP catalyzed activation i.e. formation of NAPQI.
CONCLUSION
In conclusion, the present study demonstrates that HMEE possess 
hepatoprotective activity. In addition, the hepatoprotective property 
may be attributed to the polyphenolic compounds of plant, namely 
tannins and flavonoids. Further investigation is going on to isolate, 
characterize, and screen the active principles that possess anti-oxidant 
and hepatoprotective property.
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